Reducing radiation exposure in the heart cath lab using RAMPART

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adult coronary intervention procedures performed with X-ray guidance will be randomized to either use the RAMPART radiation protection device or standard lead-based protection. Operators and cath lab team members will wear dosimeters to record per-procedure radiation dose, and doses will be compared between the two groups. The trial enrolls adults undergoing elective or urgent coronary intervention via right or left radial access and excludes femoral approaches, pregnancy, and those unable to consent. Secondary data will capture feasibility, operator comfort, and implications for use of lighter or no lead protection.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* All procedures involving adult patients (\>18 year of age)
* Male or female patients
* Planned to undergo either an elective or urgent coronary intervention procedure involving ionising radiation in the cardiac catheter lab, via the right and or left radial arteries.

Exclusion Criteria:

* Procedures involving patients less than 18 years of age
* Patients unable to give valid consent
* Pregnancy
* Femoral approach procedure

Where it's running

• Liverpool Heart & Chest Hospital
  Liverpool, United Kingdom Recruiting

Study contacts

• Study coordinator: John D Hung, MBChB PhD MRCP(UK)
• Email: paula.walker@lhch.nhs.uk
• Phone: 0151 600 1657

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Next-Gen Fluoroscopy System vs Conventional System in Endoscopy

  This trial tests whether a next-generation fluoroscopy system lowers radiation exposure for patients and staff during fluoroscopy-guided endoscopic procedures.

  Recruiting Orlando Health, Inc. · Orlando, Florida · NCT07594132

• Operator radiation dose during PCI: left distal radial access vs right conventional radial access

  This study tests whether using the left distal radial approach during PCI leads to different radiation exposure for the operator compared with the standard right radial approach in adult patients.

  Recruiting Yonsei University · Osaka and 3 other locations · NCT07579169

• Exoskeleton-supported protection versus lead apron during endovascular aortic repair

  This study will test whether using an exoskeleton-supported radiation protection system can lower radiation exposure and reduce muscle strain for vascular surgeons doing complex endovascular aortic repairs.

  Recruiting Samodzielny Publiczny Szpital Kliniczny nr 2 PUM · Szczecin, West Pomeranian Voivodeship · NCT07528144

• Oral 5‑strain probiotic to reduce bowel side effects during pelvic radiation

  This pilot will try giving an oral 5‑strain probiotic (Pendulum Glucose Control) to adults receiving pelvic radiation to see if it safely reduces gastrointestinal side effects.

  Recruiting Early Phase 1 University of Cincinnati · Cincinnati, Ohio · NCT07231588

• Skipping the clinical target volume (CTV) around the primary tumor in limited-stage small cell lung cancer

  This trial tests whether giving chest radiotherapy that skips the usual extra margin around the main tumor is as effective and causes fewer side effects for people with limited-stage small cell lung cancer who have responded to initial chemotherapy.

  Recruiting at 2 sites Phase 3 Sun Yat-sen University · Guangzhou, Guangdong and 1 other locations · NCT07008716

• First-line bevacizumab versus dexamethasone for symptomatic cerebral radiation necrosis after radiation for high-grade glioma or brain metastases.

  This trial will test whether first-line bevacizumab or dexamethasone works better at reducing symptoms in adults with symptomatic cerebral radiation necrosis after radiation for high-grade glioma or brain metastases.

  Recruiting at 5 sites Phase 3 The Netherlands Cancer Institute · Amsterdam and 5 other locations · NCT06888817

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.